Pnina Fishman
Founder en CAN-FITE BIOPHARMA LTD. .
Fortuna: 1 918 $ al 29/02/2024
Perfil
Founder of Can-Fite BioPharma Ltd., Pnina Fishman currently is Executive Chairman & Chief Scientific Officer at this company.
Dr. Fishman is also on the board of Eyefite Ltd., Consulting F.D.
International Marketing & Engingeering Ltd., Ultratrend Ltd.
and Fd Consulting Ltd.
In her past career Dr. Fishman held the position of Professor at Rabin Medical Center Beilinson, Chairman & Chief Executive Officer for OphthaliX, Inc. and Chief Executive Officer at Mor Research Applications Ltd.
Pnina Fishman received a doctorate from Bar-Ilan University.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
CAN-FITE BIOPHARMA LTD.
0.02% | 30/03/2023 | 263 433 ( 0.02% ) | 1 918 $ | 29/02/2024 |
Cargos activos de Pnina Fishman
Empresas | Cargo | Inicio |
---|---|---|
CAN-FITE BIOPHARMA LTD. | Founder | 11/09/1994 |
Consulting F.D. International Marketing & Engingeering Ltd. | Director/Board Member | - |
Eyefite Ltd.
Eyefite Ltd. BiotechnologyHealth Technology Eyefite Ltd. provides ophthalmology research and develops pharmaceutical products. The company is headquartered in Ramat Gan, Israel. | Director/Board Member | - |
Ultratrend Ltd. | Director/Board Member | - |
Fd Consulting Ltd. | Director/Board Member | - |
Antiguos cargos conocidos de Pnina Fishman.
Empresas | Cargo | Fin |
---|---|---|
Rabin Medical Center Beilinson
Rabin Medical Center Beilinson Hospital/Nursing ManagementHealth Services Rabin Medical Center Beilinson provides hospital medical services. The private company is based in Petach Tikva, Israel. The CEO of the Israeli company is Eyran Halpern. | Corporate Officer/Principal | - |
Mor Research Applications Ltd. | Chief Executive Officer | - |
OphthaliX, Inc.
OphthaliX, Inc. Pharmaceuticals: MajorHealth Technology OphthaliX, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic products for ophthalmic disorders. Its portfolio includes CF101 oral drug that intends to treat glaucoma and uveitis. The company was founded by Ilan Cohn on December 10, 1999 and is headquartered in Petach Tikva, Israel. | Chief Executive Officer | - |
Formación de Pnina Fishman.
Bar-Ilan University | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
CAN-FITE BIOPHARMA LTD. | Health Technology |
Empresas privadas | 7 |
---|---|
OphthaliX, Inc.
OphthaliX, Inc. Pharmaceuticals: MajorHealth Technology OphthaliX, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic products for ophthalmic disorders. Its portfolio includes CF101 oral drug that intends to treat glaucoma and uveitis. The company was founded by Ilan Cohn on December 10, 1999 and is headquartered in Petach Tikva, Israel. | Health Technology |
Mor Research Applications Ltd. | |
Rabin Medical Center Beilinson
Rabin Medical Center Beilinson Hospital/Nursing ManagementHealth Services Rabin Medical Center Beilinson provides hospital medical services. The private company is based in Petach Tikva, Israel. The CEO of the Israeli company is Eyran Halpern. | Health Services |
Eyefite Ltd.
Eyefite Ltd. BiotechnologyHealth Technology Eyefite Ltd. provides ophthalmology research and develops pharmaceutical products. The company is headquartered in Ramat Gan, Israel. | Health Technology |
Consulting F.D. International Marketing & Engingeering Ltd. | |
Ultratrend Ltd. | |
Fd Consulting Ltd. |